Evidence map›Paper›PMID 40866814›Full record

SynthesisBMC neurology2025

Exploring the potential of deep brain stimulation in managing cluster headache: a systematic review.

Olivier Uwishema, Sanobar Shariff, Judy Ahmad El Chakik, Lydia Daniel Bisetegn, Omar Alomari, Magda Wojtara

Abstract readSystematic Review
In one paragraph

Synthesis in BMC neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Olivier UwishemaDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda. uwolivier1@gmail.com.ORCID http://orcid.org/0000-0002-0692-9027
Sanobar ShariffDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda.ORCID http://orcid.org/0000-0002-2915-958X
Judy Ahmad El ChakikDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda.
Lydia Daniel BisetegnDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda.
Omar AlomariDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda.ORCID http://orcid.org/0000-0003-3651-4129
Magda WojtaraDepartment of Research and Education, Oli Health Magazine Organization, Research, and Education, Kigali, Rwanda.ORCID http://orcid.org/0000-0001-6903-0206

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe debilitating nature of cluster headache (CH) is typified by intense, repeated cephalgia that are often referred to as "suicide headaches" owing to their severity. Individuals may not respond appropriately to therapeutic interventions despite various alternatives being readily available. This warrants an investigation into further management options. One of the promising solutions for CH has been identified as deep brain stimulation (DBS), which specifically targets the posterior hypothalamus.

aimThis systematic review aims to summarize the current literature on the safety and efficacy of DBS in the management of CH. METHOD AND MATERIALS: A comprehensive literature search identified 15 relevant studies comprising clinical trials, case reports, and observational studies from Embase, Web of Science, PubMed/MEDLINE, Scopus, and the Cochrane Library using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2020 standards.

resultsThe systematic review elucidated that DBS, with a focus on the posterior hypothalamus, facilitated significant reductions in the frequency, severity, and duration of cephalgic 'attacks' associated with CH observed. While individual responses varied, DBS was generally well-tolerated, with transient and reversible adverse effects involving focal neurological deficits (i.e., diplopia) being the most common. Importantly, long-term benefits were observed in vast populations, improving their overall quality of life. Furthermore, DBS demonstrated effects beyond localized hypothalamic stimulation, with evidence suggesting modulation of the pain processing network. Additionally, DBS was found to alleviate nocturnal CH attacks without disrupting circadian rhythms. These findings suggest that DBS holds promise as a therapeutic option for CH, particularly in individuals refractory to other treatments.

conclusionExisting research suggests that DBS, particularly when targeting the posterior hypothalamus, can significantly reduce CH 'attack' frequency, severity, and duration. Further research should focus on patient selection criteria and a deeper understanding of the mechanisms underpinning DBS to optimize its effectiveness in managing such a disabling cephalgia.

Indexed as

Cluster HeadacheDeep Brain StimulationHumansCluster headacheDeep brain stimulationHeadache managementHypothalamusNeurological disorderTreatment

Identifiers

PMID40866814
PMCPMC12382023

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.